Cite
HARVARD Citation
Gordon, K. et al. (2018). Anxiety and depression in patients with moderate‐to‐severe psoriasis and comparison of change from baseline after treatment with guselkumab vs. adalimumab: results from the Phase 3 VOYAGE 2 study. Journal of the European Academy of Dermatology and Venereology. pp. 1940-1949. [Online].